栄養補助食品市場 : 2027 年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年11月

栄養補助食品市場 : 種類 (プロバイオティクス、タンパク質、アミノ酸、植物化学物質と植物抽出物、繊維と特殊炭水化物)、用途 (食品、飲料、動物栄養、栄養補助食品)、形態、地域別 – 2027 年までの世界予測
Nutraceutical Ingredients Market by Type (Probiotics, Proteins, Amino Acids, Phytochemicals & Plant Extracts, Fibers & Specialty Carbohydrates), Application (Food, Beverages, Animal Nutrition, Dietary Supplements), Form & Region – Global Forecast to 2027

ページ数 354
図表数 323
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The market for nutraceutical ingredients is estimated at USD 185.2 Billion in 2022; it is projected to grow at a CAGR of 7.2% to reach USD 261.7 Billion by 2027.

栄養補助食品市場 : 種類 (プロバイオティクス、タンパク質、アミノ酸、植物化学物質と植物抽出物、繊維と特殊炭水化物)、用途 (食品、飲料、動物栄養、栄養補助食品)、形態、地域別 - 2027 年までの世界予測

Nutraceutical ingredients are substances that are used to improve health, prevent chronic diseases, increase life expectancy, slow the aging process, or support the body’s systems. Nutraceutical ingredients are viewed as more of a preventive measure than a cure. Because these ingredients work on specific problems, they are frequently used as an ingredient in the formulation of products. Industries like food, beverage, dietary supplement, animal nutrition, and personal care are some of the most applied in their product formulation. These products are becoming more popular in the market due to their nutritional benefits and compatibility with people’s lifestyles. Immunity boosters, bone & health, cardiovascular health, mental wellness, infant nutrition, weight loss management, and other nutraceutical products are currently popular. People’s awareness of health and holistic wellness has grown over the last few years. The fast-paced lifestyle of the majority of the population influenced the rise in the nutraceutical ingredient market as people began looking for alternative’s nutrition.

The probiotics nutraceutical product by type is projected to have the highest market share in terms of value in nutraceutical ingredient market throughout the forecast period.
The increasing technology improvements and scientific advancement have made the probiotic industry grow over the last two decades. Probiotic strains are considered to be difficult and expensive to manufacture, as these strains need special environment & medium to grow, temperature, and can take longer time to cultivate and cannot speed up the cultivation process. And recent popularity for probiotics, and its several health benefits, their market is estimated to observe growth in nutraceutical ingredient market in the near future.

The Food segments by application is projected to have the highest market share in the global nutraceutical ingredient market.

Major companies have extensively invested on product development and innovation of nutraceutical food products. The companies have been targeting customers and understanding their needs to find better food solutions. As consumers are becoming health conscious and aware, the preference for balanced diets and healthy food has remained high. And because of their palatability, mouth feel and texture. Considering this, food producers started innovating products which can be healthy alternative. Hence, their market is estimated to gain more market share in the nutraceutical ingredient market.

The dry ingredient, by form is projected to attain the fastest market growth in the nutraceutical ingredients market throughout the forecasted period

The wide application of dry form of nutraceutical ingredients have been the key factor in its high market share as compared to liquid form. Most of the nutraceutical food product formulation uses dry form of ingredient, which also depends on the product formulation. Dry ingredients are more stable, have extended shelf life as compared to those of liquid form. Hence, dry form of ingredient projected to attain fast market growth.
Break-up of Primaries
• By Company type: Tier 1: 25%, Tier 2: 35%, Tier 3: 40%
• By Designation: Director level: 30%, C-level: 25%, and Manager level : 45%
• By Region: Europe: 28%, Asia Pacific: 33%, North America: 17%, RoW: 22%
Leading players profiled in this report
• Associated British Foods Plc (UK)
• Arla Foods Ingredients Group P/S (Denmark)
• DSM (Netherland)
• Ingredion (US)
• Tate & Lyle (UK)
• Ajinomoto Co., Inc. (Japan)
• CHR Hansen Holdings A/S. (Denmark)
• Kyowa Hakko Bio Co., Ltd. (Japan)
• Glanbia Plc (Ireland)
• Fonterra Co. Operative Group Limited (New Zealand)
• Cargill Incorporated (US)
• ADM (US)
• International Flavors & Fragrances, Inc. (US)
• BASF SE (Germany)
• Kerry Groups (Ireland)

Nutraceutical Ingredients Market by Type (Probiotics, Proteins, Amino Acids, Phytochemicals & Plant Extracts, Fibers & Specialty Carbohydrates), Application (Food, Beverages, Animal Nutrition, Dietary Supplements), Form & Region - Global Forecast to 2027

Research Coverage
This report segments the nutraceutical ingredients market on the basis of type of ingredient, application, health benefits and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the nutraceutical ingredients market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.
Reasons to buy this report
• To get a comprehensive overview of the nutraceutical ingredients market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
• To gain insights about the major countries/regions, in which the nutraceutical ingredients market is flourishing.


目次

1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
1.3.1 MARKETS COVERED 39
FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT 39
1.3.2 GEOGRAPHIC SEGMENTATION 40
FIGURE 2 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 40
1.4 INCLUSIONS & EXCLUSIONS 40
1.5 YEARS CONSIDERED 41
1.6 CURRENCY CONSIDERED 41
TABLE 1 US DOLLAR EXCHANGE RATES CONSIDERED, 2013–2018 42
1.7 UNIT CONSIDERED 42
1.8 STAKEHOLDERS 42
1.9 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 3 NUTRACEUTICAL INGREDIENTS: RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 45
2.1.2.1 Key industry insights 46
2.1.2.2 Breakdown of primary interviews 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 46
2.2 MARKET SIZE ESTIMATION 47
2.2.1 BOTTOM-UP 47
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 48
2.2.2 TOP-DOWN 48
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 49
2.2.3 SUPPLY-SIDE 49
FIGURE 7 DATA TRIANGULATION: SUPPLY-SIDE 50
2.2.4 DEMAND-SIDE 50
FIGURE 8 DATA TRIANGULATION: DEMAND-SIDE 51
2.3 DATA TRIANGULATION 52
FIGURE 9 DATA TRIANGULATION 52

2.4 RESEARCH ASSUMPTIONS & LIMITATIONS 53
2.4.1 ASSUMPTIONS 53
2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS 54
3 EXECUTIVE SUMMARY 55
TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SNAPSHOT, 2022 VS. 2027 55
FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION) 56
FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION) 57
FIGURE 12 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (USD BILLION) 57
FIGURE 13 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 58
4 PREMIUM INSIGHTS 59
4.1 ATTRACTIVE OPPORTUNITIES IN NUTRACEUTICAL INGREDIENTS MARKET 59
FIGURE 14 INCREASED CONSUMPTION OF FORTIFIED FOODS DUE TO GROWING HEALTH CONSCIOUSNESS AMONG CONSUMERS 59
4.2 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY 60
FIGURE 15 INDIA AND PROBIOTICS ACCOUNTED FOR LARGEST SHARES, BY COUNTRY AND TYPE, RESPECTIVELY 60
4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SUBMARKETS 60
FIGURE 16 JAPAN TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 60
4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION 61
FIGURE 17 ASIA PACIFIC TO DOMINATE NUTRACEUTICAL INGREDIENTS MARKET ACROSS ALL TYPES 61
4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 62
FIGURE 18 DRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 62
4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 62
FIGURE 19 DIETARY SUPPLEMENTS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MACROECONOMIC INDICATORS 63
5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 63
5.2.2 KEY FACTS 63
5.2.2.1 Aging population becoming more aware of benefits of nutraceuticals 64
FIGURE 20 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 65
FIGURE 21 AGING POPULATION IN JAPAN, 2014–2018 65
5.3 MARKET DYNAMICS 66
FIGURE 22 NUTRACEUTICAL INGREDIENTS: MARKET DYNAMICS 66
5.3.1 DRIVERS 66
5.3.1.1 Growing demand for fortified food due to increased health consciousness among consumers 66
FIGURE 23 CONSUMERS’ PERCEPTION REGARDING WHAT TO CONSUME OR AVOID 68
5.3.1.2 Increase in incidences of chronic diseases 68
FIGURE 24 PERCENTAGE OF US POPULATION WITH MULTIPLE CHRONIC ILLNESSES, 2017 69
FIGURE 25 CHRONIC DISEASES MOST PREVALENT WORLDWIDE AMONGST ALL AGES, 2019 69
FIGURE 26 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS 70
5.3.1.3 Mandates on food fortification by government organizations 71
TABLE 3 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION 72
TABLE 4 WIDELY USED FORTIFIED FOODS 73
FIGURE 27 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021 73
5.3.2 RESTRAINTS 74
5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption 74
5.3.3 OPPORTUNITIES 75
5.3.3.1 Innovations in nutraceutical ingredients industry 75
5.3.3.2 Consumer awareness of micronutrient deficiencies 77
TABLE 5 FOODS TO BOOST IMMUNE SYSTEM 78
TABLE 6 MICRONUTRIENTS DEFICIENCY CONDITIONS AND THEIR WORLDWIDE PREVALENCE 78
5.3.4 CHALLENGES 78
5.3.4.1 Consumer skepticism associated with nutraceutical products 78
6 INDUSTRY TRENDS 80
6.1 INTRODUCTION 80
6.2 VALUE CHAIN ANALYSIS 81
FIGURE 28 VALUE CHAIN: NUTRACEUTICAL INGREDIENTS MARKET 81
6.2.1 SOURCING OF RAW MATERIALS 81
6.2.2 MANUFACTURING 82
6.2.3 DISTRIBUTION, MARKETING, AND SALES 82
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 82
FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL INGREDIENTS MARKET 82
6.4 TECHNOLOGY ANALYSIS 83
6.4.1 FOOD MICROENCAPSULATION 83
6.4.1.1 Encapsulation of omega-3 to mask the odor 83
6.4.2 INNOVATIVE AND DISRUPTIVE TECH 84
6.4.2.1 Robotics leading to innovations in market 84
6.4.2.2 3D printing to uplift dietary supplements market 84
6.4.2.3 Hologram Sciences—platform for personalized nutrition and advice 84
6.5 PRICING ANALYSIS 85
FIGURE 30 PRICING ANALYSIS, 2017–2022 (USD/KG) 85

6.6 PATENT ANALYSIS 85
FIGURE 31 PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2011–2021 86
TABLE 7 KEY PATENTS PERTAINING NUTRACEUTICAL INGREDIENTS MARKET, 2021 87
6.7 MARKET MAP 88
6.7.1 UPSTREAM 88
6.7.1.1 Ingredient Manufacturers 88
6.7.1.2 Technology Providers 88
6.7.1.3 Start-ups/Emerging Companies 88
6.7.2 DOWNSTREAM 89
6.7.2.1 Regulatory Bodies 89
6.7.2.2 End Users 89
FIGURE 33 NUTRACEUTICALS INGREDIENTS MARKET MAP 90
TABLE 8 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM 90
6.8 TRADE SCENARIO 92
FIGURE 34 VITAMINS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 92
TABLE 9 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 93
FIGURE 35 VITAMINS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 93
TABLE 10 EXPORT DATA ON VITAMINS FOR KEY COUNTRIES, 2021 (VALUE) 94
FIGURE 36 AMINO ACIDS: IMPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 94
TABLE 11 IMPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 95
FIGURE 37 AMINO ACIDS: EXPORT VALUE, BY KEY COUNTRY, 2017–2021 (USD THOUSAND) 95
TABLE 12 EXPORT DATA ON AMINO ACIDS FOR KEY COUNTRIES, 2021 (VALUE) 96
6.9 KEY CONFERENCES & EVENTS IN 2022–2023 96
TABLE 13 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2022–2023 96
6.10 TARIFF AND REGULATORY LANDSCAPE 98
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101
TABLE 17 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 102
6.10.2 REGULATORY FRAMEWORK 102
6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market 102
TABLE 19 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE 103
6.10.2.2 North America 104
6.10.2.2.1 Canada 104
6.10.2.2.2 US 104
6.10.2.2.3 Mexico 104
6.10.2.3 European Union (EU) 104
6.10.2.4 Asia Pacific 105
6.10.2.4.1 Japan 105
6.10.2.4.2 China 105
6.10.2.4.3 India 105
6.10.2.4.4 Australia & New Zealand 105
6.10.2.5 Rest of the World (RoW) 106
6.10.2.5.1 Israel 106
6.10.2.5.2 Brazil 106
6.10.2.6 Probiotics 106
6.10.2.6.1 Introduction 106
6.10.2.6.2 National/International bodies for safety standards and regulations 106
TABLE 20 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 106
6.10.2.6.3 Codex Alimentarius Commission (CAC) 107
6.10.2.6.4 North America: Regulatory environment analysis 107
6.10.2.6.5 Europe: Regulatory environment analysis 108
6.10.2.6.6 Asia Pacific: Regulatory environment analysis 109
6.10.2.6.7 South America: Regulatory environment analysis 110
6.10.2.7 Prebiotics 110
6.10.2.7.1 Introduction 110
6.10.2.7.2 Asia Pacific 110
TABLE 21 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015 111
6.10.2.7.3 North America 111
TABLE 22 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 112
6.10.2.7.4 European Union 113
6.11 PORTER’S FIVE FORCES ANALYSIS 113
TABLE 23 NUTRACEUTICAL INGREDIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 113
6.11.1 DEGREE OF COMPETITION 113
6.11.2 BARGAINING POWER OF SUPPLIERS 114
6.11.3 BARGAINING POWER OF BUYERS 114
6.11.4 THREAT OF SUBSTITUTES 114
6.11.5 THREAT OF NEW ENTRANTS 115
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 115
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 115
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES 116
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TYPES (%) 116
6.12.2 BUYING CRITERIA 116
TABLE 25 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 116
FIGURE 39 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR 117
6.13 CASE STUDY ANALYSIS 117
6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY 117
6.13.2 MINDRIGHT’S BARS HELP COMBAT MENTAL HEALTH ISSUES 118
7 NUTRACEUTICAL INGREDIENTS MARKET, BY HEALTH BENEFITS 119
7.1 INTRODUCTION 119
7.2 COGNITIVE HEALTH 119
7.3 GUT HEALTH 120
7.4 HEART HEALTH 120
7.5 BONE HEALTH 121
TABLE 26 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE 121
7.6 IMMUNITY 122
7.7 NUTRITION 122
7.8 WEIGHT MANAGEMENT 122
7.9 OTHERS 123
8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE 124
8.1 INTRODUCTION 125
FIGURE 40 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022 VS. 2027 (BY VALUE) 125
TABLE 27 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 126
TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 126
TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT) 127
TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT) 127
8.2 PROBIOTIC 128
8.2.1 HIGH DEMAND FOR SCIENTIFICALLY PROVEN HEALTH FOODS AND DIETARY SUPPLEMENTS 128
TABLE 31 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 130
TABLE 32 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 130
TABLE 33 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 130
TABLE 34 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 131

8.3 PROTEINS & AMINO ACIDS 131
8.3.1 IMPORTANT INGREDIENTS IN FOOD AND FEED INDUSTRIES 131
TABLE 35 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 133
TABLE 36 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 133
TABLE 37 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 133
TABLE 38 PROTEINS & AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 134
8.4 PHYTOCHEMICALS & PLANT EXTRACTS 134
8.4.1 GROWING DEMAND FOR ORGANIC FOOD PRODUCTS AND INGREDIENTS 134
TABLE 39 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS 135
TABLE 40 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 135
TABLE 41 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 135
TABLE 42 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 136
TABLE 43 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 136
8.5 FIBERS & SPECIALTY CARBOHYDRATES 136
8.5.1 ADDED TO FUNCTIONAL FOOD & BEVERAGES MORE FREQUENTLY 136
TABLE 44 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 137
TABLE 45 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 138
TABLE 46 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 138
TABLE 47 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 138
8.6 OMEGA-3 FATTY ACIDS 139
8.6.1 INCREASED USE OF OMEGA-3 TO ENHANCE HEART AND BRAIN HEALTH 139
TABLE 48 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 140
TABLE 49 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 140
TABLE 50 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 140
TABLE 51 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 141
8.7 VITAMINS 141
8.7.1 AWARENESS, WIDE ACCEPTANCE, AND EASY AVAILABILITY DRIVE DEMAND 141
TABLE 52 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 142
TABLE 53 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 142
TABLE 54 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 143
TABLE 55 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 143
8.8 PREBIOTICS 143
8.8.1 USED AS TEXTURE ENHANCEMENT AND SWEETENING AGENTS 143
TABLE 56 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 144
TABLE 57 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 145
TABLE 58 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 145
TABLE 59 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 145
8.9 CAROTENOIDS 146
8.9.1 GROWING FOOD ADDITIVES AND PERSONAL CARE INDUSTRIES TO PROPEL DEMAND 146
TABLE 60 SOURCES OF CAROTENOIDS IN FRUIT AND VEGETABLES AND THEIR MEDICINAL PROPERTIES 147
TABLE 61 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 147
TABLE 62 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 148
TABLE 63 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 148
TABLE 64 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 148
8.10 MINERALS 149
8.10.1 SEVERAL HEALTH ADVANTAGES ASSOCIATED WITH MINERALS 149
TABLE 65 MACROMINERALS & THEIR FUNCTIONS 150
TABLE 66 MICROMINERALS & THEIR FUNCTIONS 150
TABLE 67 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 151
TABLE 68 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 151
TABLE 69 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 152
TABLE 70 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 152
8.11 OTHER TYPES 152
TABLE 71 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 153
TABLE 72 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 154
TABLE 73 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (KT) 154
TABLE 74 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (KT) 154
9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM 155
9.1 INTRODUCTION 156
FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022 VS. 2027 (BY VALUE) 156
TABLE 75 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 157
TABLE 76 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 157
9.2 DRY 157
9.2.1 BETTER STABILITY AND EASE OF HANDLING 157
TABLE 77 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 158
TABLE 78 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 158
9.3 LIQUID 158
9.3.1 LIMITED APPLICATIONS COMPARED TO DRY FORM 158
TABLE 79 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 159
TABLE 80 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 159
10 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION 160
10.1 INTRODUCTION 161
FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022 VS. 2027 (VALUE) 161
TABLE 81 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 162
TABLE 82 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 162
10.2 FOOD 162
TABLE 83 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 163
TABLE 84 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 163
10.2.1 SNACKS 163
10.2.1.1 Inclination toward protein-rich foods 163
10.2.2 CONFECTIONERY 164
10.2.2.1 Nutraceutical ingredients enhance texture, stability, and flavor 164
10.2.3 BAKERY 164
10.2.3.1 Adding omega-3 fatty acids lowers baking defects 164
10.2.4 DAIRY 165
10.2.4.1 Rising consumer awareness of health advantages of dairy products 165
10.2.5 MEAT & MEAT PRODUCTS 166
10.2.5.1 Major source of protein 166

10.2.6 BABY FOOD 166
10.2.6.1 High standards of living and preference for convenience foods 166
TABLE 85 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS 167
TABLE 86 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS 167
10.2.7 OTHERS 167
FIGURE 43 GLOBALLY RISING IMPORTS AND EXPORTS OF CEREALS AND CEREAL PRODUCTS, 2016–2020 168
TABLE 87 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 168
TABLE 88 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 169
10.3 BEVERAGES 169
TABLE 89 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 170
TABLE 90 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 170
10.3.1 ENERGY DRINKS 170
10.3.1.1 Offer specific medical and health benefits 170
10.3.2 JUICES 171
10.3.2.1 Functional benefits and growing health concerns 171
10.3.3 HEALTH DRINKS 171
10.3.3.1 Improves quality by reducing health risks 171
TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2017–2021 (USD MILLION) 172
TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET FOR BEVERAGES, BY SUB-APPLICATION, 2022–2027 (USD MILLION) 172
10.4 PERSONAL CARE 172
10.4.1 PREFERENCE FOR ORGANIC PERSONAL CARE PRODUCTS. 172
TABLE 93 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 173
TABLE 94 PERSONAL CARE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 174
10.5 ANIMAL NUTRITION 174
10.5.1 RISING ANIMAL HEALTH AND NUTRITION MARKET 174
TABLE 95 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 175
TABLE 96 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 175
10.6 DIETARY SUPPLEMENTS 176
10.6.1 OFFER SEVERAL HEALTH BENEFITS 176
TABLE 97 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 177
TABLE 98 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 177
11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION 178
11.1 INTRODUCTION 179
TABLE 99 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 179
TABLE 100 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 180
FIGURE 44 REGIONAL SNAPSHOT: US ACQUIRED LARGEST SHARE IN NUTRACEUTICAL INGREDIENTS MARKET, 2021 180
11.2 NORTH AMERICA 181
TABLE 101 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 181
TABLE 102 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 181
TABLE 103 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 182
TABLE 104 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 182
TABLE 105 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 183
TABLE 106 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 183
TABLE 107 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 183
TABLE 108 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 184
11.2.1 US 184
11.2.1.1 Improved quality of livestock-based products amid increased consumer demand 184
TABLE 109 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 185
TABLE 110 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 185
11.2.2 CANADA 186
11.2.2.1 Increased government support for R&D 186
FIGURE 45 CANADA: OVERWEIGHT OR OBESE, BY AGE GROUP AND SEX, 2018 187
TABLE 111 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 187
TABLE 112 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 188
11.2.3 MEXICO 188
11.2.3.1 Growing health and wellness trends 188
FIGURE 46 MEXICO: PER CAPITA EXPENDITURE ON FOOD, 2010–2018 188
TABLE 113 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 189
TABLE 114 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 190

11.3 EUROPE 190
TABLE 115 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 191
TABLE 116 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 191
TABLE 117 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 192
TABLE 118 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 192
TABLE 119 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 193
TABLE 120 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 193
TABLE 121 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 193
TABLE 122 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 193
11.3.1 GERMANY 194
11.3.1.1 Multiple applications of nutraceuticals in food & beverages and personal care products. 194
TABLE 123 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 195
TABLE 124 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 195
11.3.2 FRANCE 196
11.3.2.1 Increased health awareness and strategic government initiatives 196
TABLE 125 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 197
TABLE 126 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 197
11.3.3 UK 198
11.3.3.1 High demand for nutraceutical ingredients from food & beverage industry 198
TABLE 127 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 199
TABLE 128 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 199
11.3.4 ITALY 200
11.3.4.1 Increased consumption of food supplements 200
TABLE 129 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 200
TABLE 130 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 201
11.3.5 SPAIN 201
11.3.5.1 Preference for functional food and beverages 201
TABLE 131 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 202
TABLE 132 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 202
11.3.6 RUSSIA 203
11.3.6.1 Complicated and expensive registration process 203
TABLE 133 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 203
TABLE 134 RUSSIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 204
11.3.7 REST OF EUROPE 204
TABLE 135 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 205
TABLE 136 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 205
11.4 ASIA PACIFIC 206
FIGURE 47 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, 2021 207
TABLE 137 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 207
TABLE 138 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 208
TABLE 139 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 208
TABLE 140 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 209
TABLE 141 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 209
TABLE 142 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 210
TABLE 143 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 210
TABLE 144 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 210
11.4.1 CHINA 210
11.4.1.1 Changing lifestyles of consumers 210
TABLE 145 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 212
TABLE 146 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 212
11.4.2 JAPAN 213
11.4.2.1 Preference for fortified foods over conventional ones 213
TABLE 147 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 214
TABLE 148 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 214
11.4.3 INDIA 215
11.4.3.1 High consumer demand due to rising hospitalization costs 215
TABLE 149 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 216
TABLE 150 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 216
11.4.4 AUSTRALIA & NEW ZEALAND 217
11.4.4.1 Preference for low-calorie foods to prevent chronic conditions 217
TABLE 151 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 218
TABLE 152 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 218
11.4.5 REST OF ASIA PACIFIC 219
TABLE 153 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 220
TABLE 154 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 220
11.5 SOUTH AMERICA 221
TABLE 155 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2017–2021 (USD MILLION) 221
TABLE 156 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 221
TABLE 157 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 222
TABLE 158 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 222
TABLE 159 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 223
TABLE 160 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 223
TABLE 161 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 223
TABLE 162 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 224
11.5.1 BRAZIL 224
11.5.1.1 Rising health consciousness and rapid urbanization 224
TABLE 163 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 225
TABLE 164 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 225
11.5.2 ARGENTINA 226
11.5.2.1 Affinity toward healthy foods and functional beverages 226
FIGURE 48 PREVALENCE OF UNDERNOURISHMENT IN ARGENTINA, 2012–2019 226
TABLE 165 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 227
TABLE 166 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 227
11.5.3 REST OF SOUTH AMERICA 228
TABLE 167 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 228
TABLE 168 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 229
11.6 REST OF THE WORLD (ROW) 229
TABLE 169 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION) 230
TABLE 170 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION) 230
TABLE 171 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 230
TABLE 172 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 231
TABLE 173 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2017–2021 (USD MILLION) 231
TABLE 174 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2022–2027 (USD MILLION) 232
TABLE 175 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2017–2021 (USD MILLION) 232
TABLE 176 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2022–2027 (USD MILLION) 232
11.6.1 MIDDLE EAST 232
11.6.1.1 Increased demand for healthy foods amid rising health concerns 232
TABLE 177 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 233
TABLE 178 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 234
11.6.2 AFRICA 234
11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals 234
TABLE 179 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 235
TABLE 180 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 236
12 COMPETITIVE LANDSCAPE 237
12.1 OVERVIEW 237
12.2 MARKET SHARE ANALYSIS, 2021 237
TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION (COMPETITIVE) 238
12.3 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS 238
FIGURE 49 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2017–2021 (USD BILLION) 238
12.4 STRATEGIES ADOPTED BY KEY PLAYERS 239
12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 242
12.5.1 STARS 242
12.5.2 EMERGING LEADERS 242
12.5.3 PERVASIVE PLAYERS 242
12.5.4 PARTICIPANTS 243
FIGURE 50 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS) 243
12.5.5 PRODUCT FOOTPRINT 244
TABLE 182 COMPANY FOOTPRINT, BY TYPE 244
TABLE 183 COMPANY FOOTPRINT, BY APPLICATION 245
TABLE 184 COMPANY FOOTPRINT, BY REGION 246
TABLE 185 OVERALL COMPANY FOOTPRINT 247
12.6 NUTRACEUTICAL INGREDIENTS MARKET: EVALUATION QUADRANT FOR START-UPS/SMES, 2021 248
12.6.1 PROGRESSIVE COMPANIES 248
12.6.2 STARTING BLOCKS 248
12.6.3 RESPONSIVE COMPANIES 248
12.6.4 DYNAMIC COMPANIES 248
FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 (START-UPS/SME) 249
12.6.5 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 250
TABLE 186 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY START-UPS/SMES 250
TABLE 187 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 251
12.7 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 253
12.7.1 PRODUCT LAUNCHES 253
TABLE 188 NUTRACEUTICAL INGREDIENTS: PRODUCT LAUNCHES, 2018–2022 253
12.7.2 DEALS 256
TABLE 189 NUTRACEUTICAL INGREDIENTS: DEALS, 2018–2022 256
12.7.3 OTHERS 269
TABLE 190 NUTRACEUTICAL INGREDIENTS: OTHERS, 2019-2022 269

13 COMPANY PROFILES 274
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 INTRODUCTION 274
13.2 KEY PLAYERS 275
13.2.1 ASSOCIATED BRITISH FOODS PLC 275
TABLE 191 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 275
FIGURE 52 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 276
TABLE 192 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED 276
13.2.2 ARLA FOODS AMBA 279
TABLE 193 ARLA FOODS AMBA: BUSINESS OVERVIEW 279
FIGURE 53 ARLA FOODS AMBA: COMPANY SNAPSHOT 280
TABLE 194 ARLA FOODS AMBA: PRODUCTS OFFERED 280
13.2.3 DSM 283
TABLE 195 DSM: BUSINESS OVERVIEW 283
FIGURE 54 DSM: COMPANY SNAPSHOT 284
TABLE 196 DSM: PRODUCTS OFFERED 284
TABLE 197 DSM: DEALS 286
13.2.4 INGREDION 289
TABLE 198 INGREDION: BUSINESS OVERVIEW 289
FIGURE 55 INGREDION: COMPANY SNAPSHOT 290
TABLE 199 INGREDION: PRODUCTS OFFERED 290
TABLE 200 INGREDION: PRODUCT LAUNCHES 291
TABLE 201 INGREDION: DEALS 292
TABLE 202 INGREDION: OTHERS 293
13.2.5 TATE & LYLE 294
TABLE 203 TATE & LYLE: BUSINESS OVERVIEW 294
FIGURE 56 TATE & LYLE: COMPANY SNAPSHOT 295
TABLE 204 TATE & LYLE: PRODUCTS OFFERED 295
TABLE 205 TATE & LYLE: PRODUCT LAUNCHES 296
TABLE 206 TATE & LYLE: DEALS 296
TABLE 207 TATE & LYLE: OTHERS 297
13.2.6 AJINOMOTO CO., INC. 299
TABLE 208 AJINOMOTO CO., INC.: BUSINESS OVERVIEW 299
FIGURE 57 AJINOMOTO CO., INC.: COMPANY SNAPSHOT 300
TABLE 209 AJINOMOTO CO., INC.: PRODUCTS OFFERED 300
TABLE 210 AJINOMOTO CO., INC.: DEALS 301
TABLE 211 AJINOMOTO CO., INC.: OTHERS 301
13.2.7 CHR HANSEN HOLDING A/S. 303
TABLE 212 CHR HANSEN HOLDING A/S. BUSINESS OVERVIEW 303
FIGURE 58 CHR HANSEN HOLDING A/S. COMPANY SNAPSHOT 304
TABLE 213 CHR HANSEN HOLDING A/S. PRODUCTS OFFERED 304
TABLE 214 CHR HANSEN HOLDING A/S. PRODUCT LAUNCHES 306
TABLE 215 CHR HANSEN HOLDING A/S. DEALS 307
TABLE 216 CHR HANSEN HOLDING A/S: OTHERS 308
13.2.8 KYOWA HAKKO BIO CO., LTD. 309
TABLE 217 KYOWA HAKKO BIO CO., LTD.: BUSINESS OVERVIEW 309
FIGURE 59 KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT 309
TABLE 218 KYOWA HAKKO BIO CO., LTD.: PRODUCTS OFFERED 310
13.2.9 GLANBIA PLC 311
TABLE 219 GLANBIA PLC: BUSINESS OVERVIEW 311
FIGURE 60 GLANBIA PLC: COMPANY SNAPSHOT 312
TABLE 220 GLANBIA PLC: PRODUCTS OFFERED 313
TABLE 221 GLANBIA PLC: PRODUCT LAUNCHES 314
TABLE 222 GLANBIA PLC: DEALS 315
TABLE 223 GLANBIA PLC: OTHERS 316
13.2.10 FONTERRA CO-OPERATIVE GROUP LIMITED 317
TABLE 224 FONTERRA CO.-OPERATIVE GROUP LIMITED: BUSINESS OVERVIEW 317
FIGURE 61 FONTERRA CO.-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT 318
TABLE 225 FONTERRA CO. OPERATIVE GROUP LIMITED: PRODUCTS OFFERED 318
TABLE 226 FONTERRA CO.-OPERATIVE GROUP LIMITED: DEALS 319
13.2.11 CARGILL INCORPORATED 320
TABLE 227 CARGILL INCORPORATED: BUSINESS OVERVIEW 320
FIGURE 62 CARGILL INCORPORATED: COMPANY SNAPSHOT 320
TABLE 228 CARGILL INCORPORATED: PRODUCTS OFFERED 321
TABLE 229 CARGILL INCORPORATED: PRODUCT LAUNCHES 322
TABLE 230 CARGILL INCORPORATED: DEALS 322
TABLE 231 CARGILL INCORPORATED: OTHERS 322
13.2.12 ADM 324
TABLE 232 ADM: BUSINESS OVERVIEW 324
FIGURE 63 ADM: COMPANY SNAPSHOT 325
TABLE 233 ADM: PRODUCTS OFFERED 325
TABLE 234 ADM: PRODUCT LAUNCHES 327
TABLE 235 ADM: DEALS 327
TABLE 236 ADM: OTHERS 329
13.2.13 INTERNATIONAL FLAVORS & FRAGRANCES INC. 330
TABLE 237 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW 330
FIGURE 64 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT 331
TABLE 238 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS OFFERED 331
TABLE 239 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES 332
TABLE 240 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS 332
TABLE 241 INTERNATIONAL FLAVORS & FRAGRANCES INC.: OTHERS 333
13.2.14 BASF SE 334
TABLE 242 BASF SE: BUSINESS OVERVIEW 334
FIGURE 65 BASF SE: COMPANY SNAPSHOT 335
TABLE 243 BASF SE: PRODUCTS OFFERED 335
TABLE 244 BASF SE: OTHERS 337
13.2.15 KERRY GROUP PLC 338
TABLE 245 KERRY GROUP PLC: BUSINESS OVERVIEW 338
FIGURE 66 KERRY GROUP PLC: COMPANY SNAPSHOT 339
TABLE 246 KERRY GROUP PLC: PRODUCTS OFFERED 339
TABLE 247 KERRY GROUP PLC: PRODUCT LAUNCHES 340
TABLE 248 KERRY GROUP PLC: DEALS 341
TABLE 249 KERRY GROUP PLC: OTHERS 342
13.3 OTHER PLAYERS 343
13.3.1 BALCHEM INC. 343
13.3.2 SYDLER INDIA PVT. LTD. 343
13.3.3 PROBI 344
13.3.4 DIVI’S LABORATORIES LIMITED 344
13.3.5 MARTIN BAUER 345
13.3.6 BENEO GMBH 345
13.3.7 NEXIRA 346
13.3.8 ROQUETTE FRÈRES 346
13.3.9 CONAGEN, INC. 347
13.3.10 NUTRACEUTICALS GROUPS 347
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 ADJACENT & RELATED MARKETS 348
14.1 INTRODUCTION 348
14.2 LIMITATIONS 348
14.3 FUNCTIONAL FOOD INGREDIENTS MARKET 348
14.3.1 MARKET DEFINITION 348
14.3.2 MARKET OVERVIEW 349
14.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE 349
14.3.3.1 Introduction 349
TABLE 250 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 350
TABLE 251 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 350
14.3.4 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION 351
14.3.4.1 Introduction 351
TABLE 252 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 351
TABLE 253 FUNCTIONAL FOOD INGREDIENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 351
14.4 NUTRACEUTICAL EXCIPIENTS MARKET 352
14.4.1 MARKET DEFINITION 352
14.4.2 MARKET OVERVIEW 352
14.4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 353
14.4.3.1 Introduction 353
TABLE 254 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2025 (USD MILLION) 353
TABLE 255 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2025 (KT) 354
14.4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 354
14.4.4.1 Introduction 354
TABLE 256 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 354
TABLE 257 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2025 (KT) 355
15 APPENDIX 356
15.1 DISCUSSION GUIDE 356
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 361
15.3 CUSTOMIZATION OPTIONS 363
15.4 RELATED REPORTS 363
15.5 AUTHOR DETAILS 364


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com